Cargando…
Reactive gene curation to support interpretation and reporting of a clinical genome test for rare disease: Experience from over 1,000 cases
Current standards in clinical genetics recognize the need to establish the validity of gene-disease relationships as a first step in the interpretation of sequence variants. We describe our experience incorporating the ClinGen Gene-Disease Clinical Validity framework in our interpretation and report...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932986/ https://www.ncbi.nlm.nih.gov/pubmed/36819666 http://dx.doi.org/10.1016/j.xgen.2023.100258 |
_version_ | 1784889578524508160 |
---|---|
author | Clause, Amanda R. Taylor, Julie P. Rajkumar, Revathi Bluske, Krista Bennett, Maren Amendola, Laura M. Bentley, David R. Taft, Ryan J. Perry, Denise L. Coffey, Alison J. |
author_facet | Clause, Amanda R. Taylor, Julie P. Rajkumar, Revathi Bluske, Krista Bennett, Maren Amendola, Laura M. Bentley, David R. Taft, Ryan J. Perry, Denise L. Coffey, Alison J. |
author_sort | Clause, Amanda R. |
collection | PubMed |
description | Current standards in clinical genetics recognize the need to establish the validity of gene-disease relationships as a first step in the interpretation of sequence variants. We describe our experience incorporating the ClinGen Gene-Disease Clinical Validity framework in our interpretation and reporting workflow for a clinical genome sequencing (cGS) test for individuals with rare and undiagnosed genetic diseases. This “reactive” gene curation is completed upon identification of candidate variants during active case analysis and within the test turn-around time by focusing on the most impactful evidence and taking advantage of the broad applicability of the framework to cover a wide range of disease areas. We demonstrate that reactive gene curation can be successfully implemented in support of cGS in a clinical laboratory environment, enabling robust clinical decision making and allowing all variants to be fully and appropriately considered and their clinical significance confidently interpreted. |
format | Online Article Text |
id | pubmed-9932986 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-99329862023-02-17 Reactive gene curation to support interpretation and reporting of a clinical genome test for rare disease: Experience from over 1,000 cases Clause, Amanda R. Taylor, Julie P. Rajkumar, Revathi Bluske, Krista Bennett, Maren Amendola, Laura M. Bentley, David R. Taft, Ryan J. Perry, Denise L. Coffey, Alison J. Cell Genom Short Article Current standards in clinical genetics recognize the need to establish the validity of gene-disease relationships as a first step in the interpretation of sequence variants. We describe our experience incorporating the ClinGen Gene-Disease Clinical Validity framework in our interpretation and reporting workflow for a clinical genome sequencing (cGS) test for individuals with rare and undiagnosed genetic diseases. This “reactive” gene curation is completed upon identification of candidate variants during active case analysis and within the test turn-around time by focusing on the most impactful evidence and taking advantage of the broad applicability of the framework to cover a wide range of disease areas. We demonstrate that reactive gene curation can be successfully implemented in support of cGS in a clinical laboratory environment, enabling robust clinical decision making and allowing all variants to be fully and appropriately considered and their clinical significance confidently interpreted. Elsevier 2023-01-31 /pmc/articles/PMC9932986/ /pubmed/36819666 http://dx.doi.org/10.1016/j.xgen.2023.100258 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Short Article Clause, Amanda R. Taylor, Julie P. Rajkumar, Revathi Bluske, Krista Bennett, Maren Amendola, Laura M. Bentley, David R. Taft, Ryan J. Perry, Denise L. Coffey, Alison J. Reactive gene curation to support interpretation and reporting of a clinical genome test for rare disease: Experience from over 1,000 cases |
title | Reactive gene curation to support interpretation and reporting of a clinical genome test for rare disease: Experience from over 1,000 cases |
title_full | Reactive gene curation to support interpretation and reporting of a clinical genome test for rare disease: Experience from over 1,000 cases |
title_fullStr | Reactive gene curation to support interpretation and reporting of a clinical genome test for rare disease: Experience from over 1,000 cases |
title_full_unstemmed | Reactive gene curation to support interpretation and reporting of a clinical genome test for rare disease: Experience from over 1,000 cases |
title_short | Reactive gene curation to support interpretation and reporting of a clinical genome test for rare disease: Experience from over 1,000 cases |
title_sort | reactive gene curation to support interpretation and reporting of a clinical genome test for rare disease: experience from over 1,000 cases |
topic | Short Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932986/ https://www.ncbi.nlm.nih.gov/pubmed/36819666 http://dx.doi.org/10.1016/j.xgen.2023.100258 |
work_keys_str_mv | AT clauseamandar reactivegenecurationtosupportinterpretationandreportingofaclinicalgenometestforrarediseaseexperiencefromover1000cases AT taylorjuliep reactivegenecurationtosupportinterpretationandreportingofaclinicalgenometestforrarediseaseexperiencefromover1000cases AT rajkumarrevathi reactivegenecurationtosupportinterpretationandreportingofaclinicalgenometestforrarediseaseexperiencefromover1000cases AT bluskekrista reactivegenecurationtosupportinterpretationandreportingofaclinicalgenometestforrarediseaseexperiencefromover1000cases AT bennettmaren reactivegenecurationtosupportinterpretationandreportingofaclinicalgenometestforrarediseaseexperiencefromover1000cases AT amendolalauram reactivegenecurationtosupportinterpretationandreportingofaclinicalgenometestforrarediseaseexperiencefromover1000cases AT reactivegenecurationtosupportinterpretationandreportingofaclinicalgenometestforrarediseaseexperiencefromover1000cases AT bentleydavidr reactivegenecurationtosupportinterpretationandreportingofaclinicalgenometestforrarediseaseexperiencefromover1000cases AT taftryanj reactivegenecurationtosupportinterpretationandreportingofaclinicalgenometestforrarediseaseexperiencefromover1000cases AT perrydenisel reactivegenecurationtosupportinterpretationandreportingofaclinicalgenometestforrarediseaseexperiencefromover1000cases AT coffeyalisonj reactivegenecurationtosupportinterpretationandreportingofaclinicalgenometestforrarediseaseexperiencefromover1000cases |